Literature DB >> 9606808

Dysregulation of apoptosis as a mechanism of liver disease: an overview.

T Patel1, L R Roberts, B A Jones, G J Gores.   

Abstract

Apoptosis is a morphologically distinct form of cell death which occurs in a wide variety of liver diseases. In this overview chapter, we review: (1) the current definitions of apoptosis; (2) the biochemical pathways effecting apoptosis; and (3) the intracellular pathways regulating apoptosis. We also describe how apoptosis is identified in the liver and review the ligand/receptor interactions which trigger hepatobiliary apoptosis. Finally, we speculate on potential therapeutic applications for modulating apoptosis in human liver diseases. This information is meant to provide a foundation for the following chapters each focused on a specific role of apoptosis in liver diseases.

Entities:  

Mesh:

Year:  1998        PMID: 9606808     DOI: 10.1055/s-2007-1007147

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  22 in total

1.  Human intestinal and biliary cryptosporidiosis.

Authors:  Xian-Ming Chen; Nicholas F LaRusso
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

2.  Effects of sulfasalazine on lipid peroxidation and histologic liver damage in a rat model of obstructive jaundice and obstructive jaundice with lipopolysaccharide-induced sepsis.

Authors:  Musa Dirlik; Aydin Karahan; Hakan Canbaz; Mehmet Caglikulekci; Ayşe Polat; Lulufer Tamer; Suha Aydin
Journal:  Curr Ther Res Clin Exp       Date:  2009-08

Review 3.  Apoptosis: a mechanism of acute and chronic liver injury.

Authors:  M E Guicciardi; G J Gores
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

4.  Enhanced sensitivity to CD95-induced apoptosis in ob/ob mice.

Authors:  Juergen Siebler; Markus Schuchmann; Susanne Strand; Hans A Lehr; Markus F Neurath; Peter R Galle
Journal:  Dig Dis Sci       Date:  2007-04-06       Impact factor: 3.199

5.  Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus-mediated gene transfer of the antiapoptotic Bcl-2 gene.

Authors:  G Bilbao; J L Contreras; D E Eckhoff; G Mikheeva; V Krasnykh; J T Douglas; F T Thomas; J M Thomas; D T Curiel
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

6.  NF-kappaB is activated in cholestasis and functions to reduce liver injury.

Authors:  H Miyoshi; C Rust; M E Guicciardi; G J Gores
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

7.  Discovery of Highly Potent 2-Sulfonyl-Pyrimidinyl Derivatives for Apoptosis Inhibition and Ischemia Treatment.

Authors:  Li Li; Xian Jiang; Shaoqiang Huang; Zhengxin Ying; Zhaolan Zhang; Chenjie Pan; Sisi Li; Xiaodong Wang; Zhiyuan Zhang
Journal:  ACS Med Chem Lett       Date:  2017-03-01       Impact factor: 4.345

Review 8.  Apoptosis in animal models of virus-induced disease.

Authors:  Penny Clarke; Kenneth L Tyler
Journal:  Nat Rev Microbiol       Date:  2009-02       Impact factor: 60.633

Review 9.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007

10.  Shorter exposures to harder X-rays trigger early apoptotic events in Xenopus laevis embryos.

Authors:  JiaJia Dong; Sean P Mury; Karen E Drahos; Marko Moscovitch; Royce K P Zia; Carla V Finkielstein
Journal:  PLoS One       Date:  2010-01-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.